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Abstract: Coenzyme Q10 (CoQ10) is commonly consumed as an antiaging supplement at 
doses of 30–210 mg/day. The aim of the study was to determine if CoQ10 alters markers of 
antioxidant status, oxidative damage, and gene expression in aging skeletal muscle. Female 
guinea pigs aged 26 months were supplemented for 6 weeks with CoQ10 at a human equivalent 
dose of 10 mg/kg/day. Body weight, plasma CoQ10 concentration, and WBC DNA abasic sites 
were measured at weeks 0, 2, 4, and 6 of the supplementation period. At the end of supple-
mentation, concentrations of skeletal muscle CoQ10, glutathione, malondialdehyde, protein 
carbonyls, DNA abasic sites, activities of catalase and glutathione peroxidase, and the gene 
expression of cyctochrome c oxidase subunits were measured. Dietary supplementation with 
CoQ10 elevated plasma CoQ10 levels (pre 73 ± 3 nmol/L, post 581 ± 15 nmol/L, P , 0.05) and 
decreased abasic sites in WBC DNA (pre 16.8 ± 0.5 Ap/100000 bp, post 9.7 ± 0.4 Ap/100000 bp, 
P , 0.05). In contrast, all of the measures made in skeletal muscle were not different between 
groups (P . 0.05). These results indicate that dietary supplementation with CoQ10 at a dose 
of 10 mg/kg/day may be capable of increasing antioxidant protection and reducing oxidative 
damage in the plasma, but may have no effect in skeletal muscle.
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Background
Coenzyme Q10 (CoQ10), also known as ubiquinone, is a lipid soluble compound 
endogenously synthesized in cells and located in all cellular membranes.1 CoQ10 can 
act as a potent antioxidant, is an important component of the mitochondrial electron 
transport chain, and has been recognized for its antiaging properties.2 A dose of 
0.5–1 mg/kg/day of CoQ10 is required to prevent CoQ10 deficiency and to retain 
elevated CoQ10 serum and plasma levels.3,4 Many CoQ10 supplement manufacturers, 
however, recommend a dose of 1–2 mg/kg/day to alleviate age-associated symptoms 
such as decreased skeletal muscle function.
Aging can be characterized by a decline in physiological functions arising from 
progressive oxidative damage to cellular structures such as DNA, proteins, and lipids.5 
Oxidative damage may be caused by reactive oxygen species (ROS), and continual 
exposure to ROS is the rationale behind the free radical theory of aging.6 Skeletal 
muscle cells have a complex antioxidant system designed to scavenge and neutral-
ize ROS, however a decreased antioxidant capacity or heightened oxidative stress 
may overwhelm the system.7 In aging skeletal muscle there is a reduction in muscle 
mass, muscle fibre number, and muscle strength.8–10 These aging-induced changes 
Nutrition and Dietary Supplements 2010:2submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
52
Papazzo et al
in skeletal muscle have been shown to adversely affect the 
quality of life in elderly populations.11
Given the antioxidant properties of CoQ10, it is not 
surprising that studies have reported improved antioxidant 
status and decreased oxidative damage after supplementa-
tion. CoQ10 supplementation with doses of 30–60 mg/day 
elevated plasma concentrations of vitamin E in young mice, 
and protected human and rat lymphocyte DNA from oxida-
tive damage.12–15 In mice aged 24 months CoQ10 supplemen-
tation decreased the rate of superoxide anion generation in 
skeletal muscle and liver.13
In addition to acting as an antioxidant, CoQ10 has 
been shown to alter gene expression in muscle.16,17 A study 
by Linnane et al17 found that CoQ10 supplementation 
upregulated and downregulated a number of genes involved 
in transcription, cell-cycle control, and cell-signalling in 
the vastus lateralis muscle of aged humans. In a study 
by Lee et al16 it was reported that CoQ10 upregulated 
the expression of genes encoding mitochondrial electron 
transport chain proteins in the hearts of old mice. Specifically, 
cytochrome c oxidase (complex IV) subunits and ATP 
synthase (complex V) were upregulated.16 However, the effect 
that CoQ10 supplementation has on the gene expression 
of mitochondrial electron transport chain proteins in aged 
skeletal muscle has not been examined previously.
As previously mentioned CoQ10 is widely recommended 
by a range of health professionals as a dietary supplement 
and therapeutic agent at doses of 30–210 mg/day (0.4–7 mg/
kg/day for a 70 kg patient), particularly in older individuals. 
Doses in this range are known to increase plasma CoQ10 
concentrations.3,4 It is often assumed that the same dose will 
increase levels in other tissues such as skeletal muscle, and 
convey therapeutic effects such as increased antioxidant 
status and protection against oxidative damage.
Furthermore, CoQ10 is commonly consumed as an anti-
aging supplement in the wider community at a dosage of 
10 mg/kg/day, with consumers doing so in the belief that it 
will alleviate age associated symptoms in a range of organs 
such as skeletal muscle.
Given the scientific evidence presented, and the wide 
consumer usage of CoQ10 supplements, the aim of the cur-
rent study was to determine if CoQ10 at a dose equivalent 
to 10 mg/kg/day in humans alters gene expression, and 
markers of antioxidant status and oxidative damage in aged 
skeletal muscle.
A second aim was to determine the effect of this dose on 
oxidative damage in white blood cells.
Materials and methods
Animals and experimental design
Approval for this project was granted by Victoria University’s 
Animal Experimentation Ethics Committee (project num-
ber AEETH 09/03). Ex-breeding female guinea pigs aged 
26 months were randomly assigned to either a control (n = 8) 
or a CoQ10 supplemented group (n = 8), the age of these ani-
mals is comparable to 60–70 years in humans, based on the 
average life span of a guinea pig being 36 months. Guinea pigs 
were chosen as the model because, like humans, they utilize 
CoQ10 as the major electron transporter in the mitochondrial 
electron transport chain, whereas rats use CoQ9.18
Treatment group animals were supplemented with CoQ10 
at a dose of 46 mg/kg/day incorporated into their food for 
6 weeks, (Table 1). The diets used contained vitamin C 
(150 mg/g) and vitamin E (5 IU/g) and were identical except 
for the addition of CoQ10 in the supplemented diet. The dose 
of 46 mg/kg/day was selected to provide an adult human 
equivalent dose of 10 mg/kg/day19 and was based on the 
recommended daily intake of CoQ10 for healthy individuals20 
together with information provided by supplement manu-
facturers. The dose of 46 mg/kg/day was calculated using 
the dose translation formula developed by Reagan-Shaw 
et al19 to compensate for the difference in body surface area, 
oxygen utilization, caloric expenditure, basal metabolism, 
Table 1 experimental diet composition
Control CoQ10
Protein (g%) 17.6 17.6
carbohydrate (g%) 61.1 61.1
Fat (g%) 3.9 3.9
kcal/g (g%) 3.5 3.5
ingredient g
Soy protein 80 80
casein, 80 mesh 120 120
L-Methionine 5 5
corn starch 315 315
Maltodextrin 10 35 35
Sucrose 350 350
cellulose, BW200 100 100
guar gum 25 25
Lard 20 20
Soybean oil 25 25
Mineral mix S20001 75 75
Vitamin mix V20003 10 10
choline bitartrate 2 2
coQ10 0 1.80
FD&c Yellow dye #5 0.05
FD&c Blue dye #1 0.05
Total 1162 1162
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blood volume, plasma proteins, and renal function between 
humans and guinea pigs.
The supplementation period used in this study was based 
on CoQ10 supplementation studies in older humans. A pre-
vious study that supplemented aged humans with CoQ10 
found a change in gene expression in skeletal muscle after 
4 weeks.17 Thus, a 6-week supplementation period was 
selected to allow sufficient time to observe similar changes 
in our aged guinea pigs.
Animals were provided with a weighed portion of food 
on a daily basis with any remaining food weighed prior to the 
next portion of food being provided; animals were maintained 
on a 12-hour light/dark photo-period with a room temperature 
of 21 ± 2°C and weighed weekly. During the supplementation 
period at weeks 0, 2, 4, and 6, 500 µL of blood was collected 
from the saphenous vein into EDTA coated tubes for 
measurement of plasma CoQ10 concentration and DNA 
abasic sites in white blood cells (WBC).
At the end of the supplementation period animals were 
weighed and euthanized with sodium pentobarbital (70 mg/
kg). The soleus muscle was then rapidly excised, frozen in 
liquid nitrogen, and stored at −80°C until analysis of CoQ10, 
GSH and MDA concentrations, activities of catalase and 
GPx, DNA abasic sites, and the expression of cytochrome c 
oxidase subunits III and VIa. The soleus muscle was chosen 
as it has a high concentration of mitochondria compared to 
other hind limb muscles.21
Blood processing
Immediately after blood collection, samples were centri-
fuged at 1200 g for 10 minutes at 4°C. The plasma was then 
removed and stored at −80°C until biochemical analysis of 
CoQ10. The buffy coat containing WBC was also removed 
and stored at −80°C until biochemical analysis of DNA 
abasic sites.
Muscle homogenates
A 10% w/v muscle homogenate using 100 mM phosphate 
buffer, pH 7.4, was prepared from each sample in a FastPrep 
homogenizer (MP Biomedicals, Solon, OH, USA). Homo-
genates were centrifuged at 12000 g for 15 minutes at 4°C. 
The supernatant was removed, placed into a clean tube, and 
placed on ice until use. Samples were analysed for DNA 
abasic sites, CoQ10, glutathione (GSH) and malondialdehyde 
(MDA) concentrations, and glutathione peroxidase (GPx) 
and catalase activities.
Quantification of CoQ10
Plasma and muscle samples were assayed for CoQ10 
concentrations via HPLC using methods described previously.22 
Briefly, 100 µL of plasma or muscle homogenate were mixed 
with 850 µL of cold 1-propanol and 50 µL of internal standard 
(CoQ9, 2 mg/100 mL).
HPLC analyses were performed on a Shimadzu 
(LC-10AD) using a reversed-phase Microsorb-MV column 
(4.6 mm × 15 cm; 5 mm bead size) with a reversed-phase C18 
guard column (4.6 × 10 mm; 5 mm bead size). The mobile 
phase was a mixture of sodium acetate trihydrate (6.8 g), 15 mL 
glacial acetic acid, 15 mL 2-propanol, 695 mL methanol and 
275 mL hexane, pH 6, added at a flow rate of 1 mL/min.
Oxidized and reduced CoQ10 were monitored by coulo-
metric detection. Total CoQ10 was determined by summing 
the oxidized (Ubiquinone-10) and reduced (Ubiquinol-10) 
forms. CoQ10 in plasma samples was expressed as nmol/L 
and in muscle samples it was expressed as pmol/mg 
protein.
glutathione assay
Total GSH in muscle was determined using the Northwest 
Life Science Specialities assay kit (NWLSS, USA), which is 
based on the principle that 5,5-dithiobis(2-nitrobenzoic acid) 
(DTNB) reacts with GSH causing a color increase which is 
measured spectrophotometrically at 405 nm.
The assay was conducted using a Cary 300 UV-Vis 
spectrophotometer (Varian, Australia).
glutathione peroxidase assay
The activity of GPx in muscle was determined using the 
Northwest Life Science Specialities assay kit, which is based 
on a modification of the method of Paglia & Valentine.23 
GPx oxidizes reduced glutathione (GSH) as it breaks down 
H
2
O
2
 forming GSSG. GSSG is then reduced by glutathione 
reductase and NADPH forming NADP+ (leading to a decrease 
in absorbance at 340 nm) and recycling the GSH.
GPx activity was measured spectrophotometrically 
using a Cary 300 UV-Vis spectrophotometer (Varian). One 
unit of GPx is defined as the amount of enzyme necessary 
to catalyse the oxidation (by H
2
O
2
) of 1.0 µMole GSH to 
GSSH per minute.
catalase activity
Catalase activity in muscle was determined using the 
Northwest Life Science Specialities assay kit, which 
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is based on a modification of the method of Beers & 
Sizer.24
Catalase activity was measured by observing the 
consumption of H
2
O
2
 substrate. Catalase activity was 
measured spectrophotometrically at 240 nm using a Cary 
300 UV-Vis spectrophotometer (Varian). One unit of catalase 
activity is defined as the amount of enzyme that will break 
down 1.0 µMole H
2
O
2
 substrate per minute.
Malondialdehyde assay
MDA, an end product of lipid peroxidation and marker 
of oxidative damage, was determined in muscle using the 
Northwest Life Science Specialities assay kit. The assay is 
based on the principle that thiobarbituric acid (TBA) reacts 
with MDA to form a TBA-MDA adduct, which is measured 
spectrophotometrically at an absorbance of 532 nm.
The assay was conducted using a Cary 300 UV-Vis spec-
trophotometer (Varian).
Protein carbonyl assay
Protein carbonyls, formed by oxidative damage to proteins, 
were determined in muscle using the the Biocell PC test kit 
(BioCell, New Zealand). The assay is based on the principle 
that the quantity of protein carbonyls in a protein sample can 
be determined by derivatising with dinitrophenylhydrazine 
(DNP) and measuring bound DNP immunologically.
The assay was conducted using a Perkin-Elmer Fusion-
Alpha HT universal microplate analyzer.
Oxidative damage to DNA
Abasic sites, an end product of oxidative damage to DNA, were 
determined in genomic DNA from muscle and white blood 
cells (WBC) using a DNA damage quantification kit (Dojindo 
Molecular Technologies, USA) according to the manufactures 
instructions. The kit measures the number of abasic sites pres-
ent in DNA as a measure of oxidative damage.
reverse transcription-real-time Pcr 
measurement of mrNA
The gene expression of two cytochrome c oxidase (complex IV) 
subunits in the mitochondrial electron transport chain of 
muscle were determined. Complex IV was chosen based 
on previous reports showing that CoQ10 supplementation 
increased the gene expression of cytochrome c oxidase sub-
units in the hearts of mice.16
Cytochrome c oxidase is made up of 13 subunits; three 
mitochondrial DNA encoded and 10 nuclear DNA encod-
ed.25 Subunit III was chosen as an example of mitochondrial 
encoded DNA, and subunit VIa was chosen as an example 
of nuclear encoded DNA.
RNA was extracted from the soleus muscle using TRI 
reagent (Molecular Research Centre, USA) following the 
manufactures instructions. Total RNA concentration was 
determined spectrophotometrically at 260 nm and then first-
strand cDNA was generated from 1 µg RNA using AMV RT 
(Promega, Australia). The cDNA was stored at −20°C for 
subsequent analysis.
Primer sequences for the selected genes were designed 
using primer3. Real-time PCR primers for subunit III were: 
Forward primer: 5′-AGG ATT TTG ACC ACC AGC AG-3′; 
Reverse primer: 5′-TCA GAT GGG GTT TAT GGC TC-3′. 
Real-time PCR primers for subunit VIa were: Forward 
primer: 5′TGT GAG GGC CCT GAG TAG G-3′; Reverse 
primer: 5′-ATT CAT CCC CTA CCA CCA CC-3′. Real-time 
PCR primers for beta-actin were: Forward primer: 5′-GCT 
GTC CGG AGA CAC TCT TC-3′; Reverse primer: 5′-TGC 
TGA TCG TAT GCA AAA GG-3′.
Real-time PCR was performed using MiniOpticon System 
(BioRad, Australia) with PCR reactions performed using iQ 
SYBR Green Supermix (BioRad, Australia). To compensate 
for variations in input RNA amounts and efficiency of reverse 
transcription, Beta-actin was quantified and all results were 
normalized to these values. Fluorescent emission data were 
captured and mRNA levels were analyzed using the critical 
threshold (C
T
) value. The relative expression of the gene of 
interest was calculated using the expression 2-∆CT and reported 
as arbitrary units.
Statistical analysis
All data was found to be normally distributed. Comparisons 
between groups for the muscle markers of antioxidant status, 
oxidative damage, and gene expression were made by inde-
pendent t-tests. Comparisons between groups for animal body 
weight data, plasma CoQ10 concentration, and WBC DNA 
oxidative damage were analyzed using repeated measures 
ANOVA. A post hoc pair-wise comparison using a Student 
Newman–Keuls test was also carried out.
Significance was established at the 95% confidence level 
(P , 0.05). All data are shown as the mean ± SEM.
Results
Body weight and food intake
No adverse effects were observed in either group of guinea 
pigs throughout the study. Body mass was not significantly 
different between groups throughout the CoQ10 supple-
mentation period (P . 0.05). Average food intake for the 
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supplemented group was 30.1 ± 1.5 g/day and the control 
group 29.7 ± 1.6 g/day. This diet provided the supple-
mented guinea pigs with a CoQ10 dose of 46.6 ± 2.3 mg/
kg/day.
effect of coQ10 supplementation  
on plasma concentration of coQ10
CoQ10 supplementation at a dose equivalent to 10 mg/kg/day 
in humans significantly increased the plasma concentration 
of ubiquinol-10, ubiquinone-10, and total CoQ10 at weeks 
2, 4 and 6 (P , 0.05, Table 2). The concentrations of ubiqui-
nol-10, ubiquinone-10, and total CoQ10 increased from 
64 ± 4 nmol/L, 9 ± 2 nmol/L and 73 ± 3 nmol/L at week 0 
to 511 ± 15 nmol/L, 70 ± 4 nmol/L and 581 ± 15 nmol/L at 
week 6 respectively.
effect of coQ10 supplementation  
on WBc DNA abasic sites
CoQ10 supplementation caused a significant decrease 
in WBC DNA abasic sites at 4 and 6 weeks (P , 0.05, 
Table 2). The number of WBC DNA abasic sites decreased 
from 17 ± 0.5 abasic sites/100000 base pairs at week 0 
to 13 ± 0.4 abasic sites/100000 base pairs at week 4 and 
10 ± 0.4 abasic sites/100000 base pairs at week 6.
effect of coQ10 supplementation  
on markers of skeletal muscle  
antioxidant status
CoQ10 supplementation did not significantly alter GSH con-
centration, or the activities of catalase and GPx (P . 0.05, 
Table 3). Ubiquinol-10, ubiquinone-10 and total CoQ10 
concentrations in skeletal muscle were also not significantly 
different between groups (P . 0.05, Table 3).
effect of coQ10 supplementation  
on markers of oxidative damage  
in skeletal muscle
MDA concentrations, protein carbonyl levels and DNA 
abasic sites in the soleus muscle of control and CoQ10 
supplemented guinea pigs were not significantly different 
between groups (Table 4).
effect of coQ10 supplementation  
on skeletal muscle gene expression
CoQ10 supplementation did not signif icantly alter 
the expression of cytochrome c oxidase subunit III 
(123 ± 56% of control) or subunit VIa (176 ± 60% of 
control).
Discussion
In the present study baseline plasma total CoQ10 levels 
were approximately ten times lower than those previously 
reported in young guinea pigs.26 The decreased amount of 
plasma CoQ10 observed in 26 month old guinea pigs sug-
gests there is an age associated decline in plasma CoQ10 
concentration.
Unfortunately this previous study in young guinea pigs 
did not measure markers of oxidative stress, therefore it is not 
possible to determine if the age associated decline in CoQ10 
levels found in the old guinea pigs used in the current study 
Table 2 Plasma coQ10 concentration and WBc DNA abasic sites. Plasma concentration of ubiquinol-10, ubiquinone-10, total 
coQ10 and WBc DNA abasic sites of aged guinea pigs supplemented with coQ10 compared to control animals. Values are expressed 
as mean ± SeM
Week of supplementation
0 2 4 6
Ubiquinol-10 (nmol/L)
control 61 ± 3 54 ± 4 59 ± 4 62 ± 7
coQ10 supplemented 64 ± 4 312 ± 9b 436 ± 16b 511 ± 15b
Ubiquinone-10 (nmol/L)
control 8 ± 1 7 ± 2 8 ± 1 7 ± 1
coQ10 supplemented 9 ± 2 42 ± 2b 60 ± 4b 70 ± 4b
Totala CoQ10 (nmol/L)
control 69 ± 4 61 ± 5 67 ± 5 69 ± 8
coQ10 supplemented 73 ± 3 354 ± 7b 496 ± 18b 581 ± 15b
DNA oxidation (abasic sites/100000 base pairs)
control 17 ± 0.2 17 ± 0.9 16 ± 0.5 17 ± 0.2
coQ10 supplemented 17 ± 0.5 16 ± 0.5 13 ± 0.4b 10 ± 0.4b
Notes: aTotal coQ10 = ubiquinol-10 + ubiquinone-10. bSignificantly different between control and treatment groups (P , 0.05).
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results from an increase in oxidative stress relative to young 
guinea pigs. However, the lower baseline levels of plasma 
CoQ10 observed in aged guinea pigs from the current study 
were reversed with CoQ10 supplementation to the point where 
after six weeks of supplementation plasma CoQ10 levels 
return to those previously reported in young guinea pigs.26
The increase in total plasma CoQ10 levels with dietary 
supplementation was the results of increased plasma con-
centrations of both ubiquinol-10 and ubiquinone-10. The 
ratio of ubiquinol-10 to ubiquinone-10 was found to be 
88:12 which is similar to the ratio found by Yamashita and 
Yamamoto27 and remained constant for the duration of the 
study in both CoQ10 supplemented and control groups. These 
results are in agreement with the findings of previous studies. 
Kwong et al12 reported an increase in CoQ10 concentration 
in the plasma of 14 month old rats after 4 and 13 weeks of 
CoQ10 dietary supplementation at a dose of 150 mg/kg/
day (equivalent to 24 mg/kg/day in humans). In another 
study, CoQ10 concentration increased in the plasma of three 
month old mice after supplementation with 148 or 645 mg/
kg/day (equivalent to 24 or 105 mg/kg/day in humans) for 
11 weeks.28 In a human study, CoQ10 supplementation at a 
dose 3 mg/kg/day for 28 days significantly increased plasma 
CoQ10 concentration.29
However, in the present study, CoQ10 supplementation 
at a dose equivalent to 10 mg/kg/day in humans did not alter 
the ubiquinol-10, ubiquinone-10 or total CoQ10 concentra-
tions in skeletal muscle. In contrast, it was shown that a dose 
of 645 mg/kg/day (equivalent to 105 mg/kg/day in humans) 
for 11 weeks increased CoQ10 levels in skeletal muscle of 
three month old mice.28
In another study using three month old mice, CoQ10 
doses of 93 or 371 mg/kg/day (equivalent to 15 or 60 mg/
kg/day in humans) for 3.5 and 17.5 months increased CoQ10 
concentrations in skeletal muscle.2
Differences in the supplementation regimes are a likely 
explanation for the difference between our results and 
previous findings. In the two aforementioned studies, the 
supplementation periods were longer, and the CoQ10 doses 
administered were higher than the present study. Indeed, 
Sohal and Forster30 indicate that although CoQ10 uptake is a 
complex process, supplementation at high doses for relatively 
long periods can result in increased skeletal muscle CoQ10 
concentration. Further studies are therefore warranted to 
determine minimum dosage and supplementation periods 
for increasing CoQ10 levels in skeletal muscle.
Our results show that dietary supplementation with 
CoQ10 decreased WBC DNA oxidation. It appears that the 
increased levels of plasma CoQ10 in the present study either 
directly or indirectly protected WBC DNA from oxidative 
damage as abasic site numbers were lower in CoQ10 supple-
mented animals. Such findings have been reported previously. 
Exposure of human lymphocytes to CoQ10 in vitro was 
protective against hydrogen peroxide induced DNA strand 
breaks.15 Another study found that CoQ10 supplementation 
in humans at a dose of 3 mg/kg/day for 28 days decreased 
the formation of 8-hydroxydeoxy-guanosine, a marker of 
oxidative damage, in human lymphocyte DNA.29
In contrast, the results from the present study show that 
dietary CoQ10 supplementation did not alter soleus DNA aba-
sic sites indicating that skeletal muscle DNA oxidation may 
not be affected by CoQ10 supplementation. The concentration 
Table 3 Antioxidant markers in skeletal muscle. Antioxidant markers in the soleus muscle of aged guinea pigs supplemented with 
coQ10 compared to control animals. Values are expressed as mean ± SeM
Marker Units Control CoQ10 supplemented
Ubiquinol-10 pmol/mg protein 26 ± 1 25 ± 1
Ubiquinone-10 pmol/mg protein 17 ± 1 18 ± 2
Total coQ10a pmol/mg protein 43 ± 1 43 ± 2
glutathione µg/mg muscle wet weight 1.37 ± 0.21 1.40 ± 0.09
glutathione peroxidase Units/mg wet weight 0.0046 ± 0.0005 0.0049 ± 0.0003
catalase Units/mg wet weight 0.88 ± 0.3 0.91 ± 0.2
Note: aTotal coQ10 = ubiquinol-10 + ubiquinone-10.
Table 4 Oxidative damage markers in skeletal muscle. Markers of oxidative damage in the soleus muscle of aged guinea pigs 
supplemented with coQ10 compared to control animals. Values are expressed as mean ± SeM
Marker Units Control CoQ10 supplemented
Malondialdehyde nM/mg muscle wet weight 35 ± 3 41 ± 3
Protein carbonyl nmol/mg protein 2.4 ± 0.4 2.5 ± 0.4
DNA oxidation abasic sites/100000 base pairs 19.5 ± 0.3 19.7 ± 0.3
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of soleus MDA and protein carbonyls was also not different 
between groups indicating that CoQ10 supplementation may 
have had no effect on lipid or protein oxidation.
These results are supported by the work of others showing 
that prolonged CoQ10 intake failed to modulate levels of 
oxidative stress in skeletal muscle from 25 month old mice.2 
Specifically, rates of superoxide production in skeletal muscle 
submitochondrial particles were unchanged after CoQ10 
supplementation at a dose of 93 or 371 mg/kg/day (equivalent 
to 15 or 60 mg/kg/day in humans) beginning at 3.5 months of 
age.2 Although an earlier finding by Lass and Sohal13 showed 
that CoQ10 intake decreased mitochondrial superoxide gen-
eration in skeletal muscle, the rate of superoxide generation 
was inversely related to mitochondrial α-tocopherol content 
but unrelated to CoQ10 content. The authors hypothesized 
that CoQ10 had a sparing effect on α-tocopherol. Taken 
together, these findings suggest that CoQ10 intake may not 
directly affect oxidative stress or directly reduce oxidative 
damage in skeletal muscle.
Our results show that at baseline muscle total CoQ10 
levels observed in 26 month old guinea pigs parallels the 
decrease plasma CoQ10 levels found in the current study 
and supports the idea there is an age associated decline 
CoQ10 concentration in a range of tissues. However, in 
the present study CoQ10 supplementation for 6 weeks at a 
dose equivalent to 10 mg/kg/day in humans did not increase 
ubiquinol-10, ubiquinone-10 or total CoQ10 concentrations 
in the soleus muscle.
As previously discussed, differences in the supplementa-
tion regimes are a likely explanation for the discrepant find-
ings. In the present study, the concentration of GSH in aged 
skeletal muscle was not affected by CoQ10 intake. In a study 
using mice, supplementation with CoQ10 did not change the 
concentration of total GSH in the liver, heart, kidney and 
brain.2 Although Sohal et al2 did not study skeletal muscle, 
their results are similar to the present study as they show no 
effect of CoQ10 supplementation on total GSH concentration 
in various tissues. The activities of catalase and GPx in the 
soleus muscle of aged guinea pigs were also not affected by 
CoQ10 supplementation. These findings are supported by 
other studies that have supplemented animals with CoQ10 
and found no effect on skeletal muscle catalase and GPx 
activity.2,12 These results indicate that CoQ10 supplementa-
tion may not alter the capacity of aged skeletal muscle to 
eliminate hydrogen peroxide.
In our study, the expression of cytochrome c oxidase 
subunits III and VIa in the soleus muscle were not different 
between control and treatment groups. In contrast, in a life 
span study, Lee et al16 found that dietary supplementation with 
CoQ10 (100 mg/kg from 14 months of age) upregulated the 
expression of genes encoding cytochrome c oxidase subunits 
and ATP synthase in the hearts of mice. The authors hypoth-
esized that the pro-oxidant form of CoQ10 results in the pro-
duction of hydrogen peroxide which may then function as a 
second messenger to inform the nucleus and the mitochondria 
to up- or downregulate genes.31 The mechanism to explain 
the conflicting results is not clear, however, it may be due to 
differences between the supplementation regimes, species, 
and tissue. It is interesting to note that Sohal et al2 reported 
no effect of CoQ10 intake on the activities of mitochron-
drial NADH-ferricytochrome c reductase (complex I/III) 
and ferrocytochrome c oxidase (complex IV) in skeletal 
muscle of 25 month old mice fed 93 or 371 mg CoQ10/kg/
day (equivalent to 15 or 60 mg/kg/day in humans) since the 
age of 3.5 months.30
Conclusion
These experiments have shown that dietary supplementation 
with CoQ10 at a dose equivalent to 10 mg/kg/day in humans 
increased CoQ10 concentration in plasma and decreased 
WBC DNA abasic sites.
In contrast, CoQ10 supplementation did not change MDA 
concentration, protein carbonyl levels, or DNA abasic sites 
in aged skeletal muscle. In addition, supplementation did not 
alter muscle GSH concentration, the activities of catalase 
and Gpx, or the gene expression of cytochrome c oxidase 
subunits III and VIa.
Although the relevance of these findings to humans is 
yet to be established, the results indicate that dietary supple-
mentation with CoQ10 at a dose of 10 mg/kg/day may be 
capable of increasing antioxidant protection and reducing 
oxidative damage in the plasma, but may have no effect in 
skeletal muscle.
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